Inhalable ciprofloxacin/polymyxin B dry powders in respiratory infection therapy
The current study focused on the formulation, physicochemical characterization, and antibacterial susceptibility testing of inhalable spray dried powders containing ciprofloxacin (CIP) and polymyxin B sulfate (PMB). CIP nanosuspensions with an average particle diameter of 435.9 ± 9.3 nm were initial...
Saved in:
| Main Authors: | Zhengqi Xu, Hriday Bera, Hengzhuang Wang, Junwei Wang, Dongmei Cun, Yu Feng, Mingshi Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2023-03-01
|
| Series: | Acta Materia Medica |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2022-0050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel multi-drugs ciprofloxacin-curcumin-N-acetylcysteine co-delivery system based on hybrid nanocrystals for dry powder inhalations
by: Yingying Ma, et al.
Published: (2024-01-01) -
INNOVATION APPROACHES TO THE DEVELOPMENT OF DRY POWDER INHALERS
by: A. N. Vorobyev, et al.
Published: (2019-01-01) -
Dry Powder Inhalers for Delivery of Synthetic Biomolecules
by: Hossein Omidian, et al.
Published: (2025-01-01) -
Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens
by: Tushar Saha, et al.
Published: (2025-02-01) -
Pulmonary delivery of insulin by dry powder inhaler formulations
by: Mohsen Imenshahidi, et al.
Published: (2025-07-01)